Sensei Biotherapeutics, Inc. (SNSE)
26.83
-2.66
(-9.02%)
USD |
NASDAQ |
Mar 26, 16:00
27.02
+0.19
(+0.71%)
After-Hours: 16:41
Sensei Biotherapeutics Cash from Investing (Quarterly) : 8.757M for June 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -4.485B |
| Tactile Systems Technology, Inc. | -0.577M |
| Eton Pharmaceuticals, Inc. | -0.049M |
| Vir Biotechnology, Inc. | 86.65M |
| Tango Therapeutics, Inc. | -135.72M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.909M |
| Cash from Financing (Quarterly) | -0.168M |
| Free Cash Flow | -24.28M |
| Free Cash Flow Per Share (Quarterly) | -4.699 |
| Free Cash Flow to Equity (Quarterly) | -5.276M |
| Free Cash Flow to Firm (Quarterly) | -5.915M |
| Free Cash Flow Yield | -6.85% |